Insider Trading Activity For Seattle Genetics, Inc. (NASDAQ:SGEN)
Jonathan G. Drachman , CMO of Seattle Genetics, Inc. (NASDAQ:SGEN) reportedly Sold 10,000 shares of the company’s stock at an average price of 54.54 for a total transaction amount of $545,400.00 SEC Form
Insider Trading History For Seattle Genetics, Inc. (NASDAQ:SGEN)
Analyst Ratings For Seattle Genetics, Inc. (NASDAQ:SGEN)
These are 3 Sell Ratings, 9 Hold Ratings, 7 Buy Ratings .
The current consensus rating for Seattle Genetics, Inc. (NASDAQ:SGEN) is Hold (Score: 2.21) with a consensus target price of $61.62 , a potential (22.01% upside)
Analyst Ratings History For Seattle Genetics, Inc. (NASDAQ:SGEN)
- On 7/27/2016 SunTrust Banks, Inc. Boost Price Target of rating Neutral with a price target of $34.00 to $38.00
- On 9/16/2016 Goldman Sachs Group, Inc. (The) Downgraded rating Neutral to Sell
- On 1/5/2017 Maxim Group Reiterated Rating Reduce
- On 1/5/2017 Royal Bank Of Canada Set Price Target of rating Buy with a price target of $80.00
- On 2/13/2017 Credit Suisse Group Boost Price Target of rating Neutral with a price target of $62.00 to $66.00
- On 2/16/2017 Bank of America Corporation Downgraded rating Neutral to Underperform
- On 3/16/2017 CIBC Initiated Coverage of rating Market Perform to Market Perform
Recent Trading Activity for Seattle Genetics, Inc. (NASDAQ:SGEN)
Shares of Seattle Genetics, Inc. closed the previous trading session at 50.50 down -0.68 -1.33% with 1,237,167 shares trading hands.